West to Highlight Industry Leadership in Packaging and Containment at CPHI Worldwide
Image File
Original HTML

EXTON, Pa., Oct. 5, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced its participation in CPHI Worldwide in Milan, Italy, where it will highlight its leadership and expertise in addressing industry challenges.

"For over a century, West has partnered with the world's leading pharmaceutical companies to help address complex drug packaging and delivery challenges," said Shane Campbell, Senior Vice President and Chief Proprietary Segment Officer at West. "At this year's CPHI, we are proud to showcase our SelfDose® patient-controlled injector, powered by the West Synchrony® S1 prefillable syringe system, which demonstrates how West is advancing patient-centered drug delivery through thoughtful design and an integrated delivery experience."

This year, West will share its industry expertise through a technical presentation and panel discussion:

- Strategic CDMO Partnerships in Combination Drug-Device Development: Accelerating Time to Market While Mitigating Risks

- Tuesday, October 6, 2:15-2:40 PM CEST, Packaging and Device Innovation Theater 11A49

- Presented by Richard Kieran, Director, Business Development

- Panel: Large Volume Drug Delivery Trade Off: The Patient Choice Dilemma

- Wednesday, October 7, 4:15-5:00 PM CEST, Packaging and Device Innovation Theater 11A49

- Dan Yates, Senior Director, Self Injection Systems

For more information about West, please visit our website.

For more information about CPHI Worldwide, please visit: CPHI Milan 2026.

Important SelfDose® product and safety information and warnings at: https://www.westpharma.com/products/self-injection-platforms/selfdose.

About West 

West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With over 10,000 team members across 50 sites including 26 manufacturing facilities worldwide, West helps support our customers by delivering over 41 billion components and devices each year. Headquartered in Exton, Pennsylvania, West in its fiscal year 2025 generated $3.07 billion in net sales. West is traded on the New York Stock Exchange (NYSE: WST) and is included in the Standard & Poor's 500 index. For more information, visit www.westpharma.com.  

SOURCE West Pharmaceutical Services, Inc.

Share this article

Class (B2B/B2C)
B2B
Ingest Status
Need Review
Dedupe hash
prn_302897745
Press Eligible
Yes
Press Eligible Reason
QA FAIL (need review): Final paragraph is a generic 'About the Company' boilerplate copied from the SOURCE's 'About West' section, adding no news context or event relevance.
Source Name
Unknown Company
Original Summary

<p>EXTON, Pa., Oct. 5, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced its participation in CPHI Worldwide in Milan, Italy, where it will highlight its leadership and expertise in...</p>

Original Link
Original Source
Image URL
https://mmx.prnewswire.com/media/MS2001103/West-Pharmaceutical-Services-SelfDose-Synchrony-Blue.jpg?id=OA2983529&p=facebook
Generated Article_json
{"target_audience": "b2b", "is_medical": true, "ai_generated_title": "West Pharma Showcases SelfDose Injector at CPHI Milan 2026", "body_html": "<p><strong>Exton, Pa. -- [CURRENT_DATE] --</strong> West Pharmaceutical Services, Inc. (NYSE: WST) will present its SelfDose® patient-controlled injector at CPHI Worldwide in Milan, Italy, positioning the device as a core offering for pharmaceutical partners seeking integrated drug-delivery systems.</p><h5>West pairs SelfDose with its Synchrony® S1 prefillable syringe platform</h5><p>The SelfDose injector is powered by West's Synchrony® S1 prefillable syringe system, combining device and container components into a single patient-administered solution. Shane Campbell, Senior Vice President and Chief Proprietary Segment Officer at West, said the company has worked with pharmaceutical manufacturers for over a century on drug packaging and delivery challenges.</p><h5>West schedules two technical sessions during the three-day trade event</h5><p>On Tuesday, October 6, Richard Kieran, Director of Business Development, will deliver a presentation titled \"Strategic CDMO Partnerships in Combination Drug-Device Development: Accelerating Time to Market While Mitigating Risks\" from 2:15-2:40 PM CEST in the Packaging and Device Innovation Theater 11A49. On Wednesday, October 7, Dan Yates, Senior Director of Self Injection Systems, will join a panel discussion, \"Large Volume Drug Delivery Trade Off: The Patient Choice Dilemma,\" running 4:15-5:00 PM CEST in the same venue.</p><h5>West generated $3.07 billion in net sales in fiscal year 2025</h5><p>The company operates 50 sites globally, including 26 manufacturing facilities, employing more than 10,000 team members. West reports delivering over 41 billion components and devices annually to drug developers worldwide. West trades on the New York Stock Exchange under the ticker WST and is a constituent of the S&P 500 index.</p>", "meta_description": "West Pharmaceutical Services showcases its SelfDose patient-controlled injector and Synchrony S1 syringe system at CPHI Worldwide in Milan, October 6-7.", "seo_keywords": "West Pharmaceutical Services, SelfDose injector, Synchrony S1, CPHI Worldwide, drug delivery, combination products, prefillable syringe", "companies": ["West Pharmaceutical Services, Inc."], "industries": ["Biopharmaceuticals"], "markets_regions": ["Europe", "Italy", "Global"], "news_type": ["product_launch", "general_news"], "products": ["SelfDose patient-controlled injector"], "themes": ["drug_delivery_innovation", "industry_event"], "events": ["CPHI Worldwide Milan 2026"], "cta_text": "Details on West's CPHI Worldwide sessions and the SelfDose injector platform are available through West Pharmaceutical Services.", "learn_more": "https://www.westpharma.com/products/self-injection-platforms/selfdose", "fact_check": {"accuracy_score": 100, "legal_risk": "low", "corrections_made": [], "recommendation": "publish"}}
Content Hash (SHA-256, erste 32 hex)
8d85878001b08cbc44ca12b02310e829